Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-158,817
Closed -$4.45M 581
2016
Q4
$4.45M Sell
158,817
-9,283
-6% -$260K 0.29% 154
2016
Q3
$4.61M Buy
168,100
+38,500
+30% +$1.06M 0.27% 150
2016
Q2
$2.83M Sell
129,600
-33,651
-21% -$734K 0.22% 169
2016
Q1
$3.65M Buy
163,251
+35,882
+28% +$801K 0.23% 179
2015
Q4
$3.51M Buy
127,369
+37,603
+42% +$1.04M 0.48% 76
2015
Q3
$2.31M Hold
89,766
0.05% 383
2015
Q2
$2.22M Buy
89,766
+29,340
+49% +$726K 0.06% 392
2015
Q1
$1.52M Hold
60,426
0.04% 560
2014
Q4
$1.42M Sell
60,426
-33,928
-36% -$796K 0.13% 166
2014
Q3
$2.15M Buy
94,354
+54,570
+137% +$1.24M 0.05% 401
2014
Q2
$973K Sell
39,784
-63,360
-61% -$1.55M 0.03% 716
2014
Q1
$2.17M Buy
103,144
+18,160
+21% +$383K 0.05% 431
2013
Q4
$2.02M Sell
84,984
-6,100
-7% -$145K 0.24% 87
2013
Q3
$1.95M Sell
91,084
-29,600
-25% -$633K 0.05% 505
2013
Q2
$2.4M Buy
+120,684
New +$2.4M 0.06% 466

Other funds holding QGENF

PDT Partners's QGENF Position: Q1 2017 in Review

PDT Partners sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 158,817 shares — an estimated $4.45M sold.

PDT Partners first reported a position in QGENF in Q2 2013 and held it in 15 quarters. The position peaked at $4.61M in Q3 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • PDT Partners reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • PDT Partners sold 158,817 QIAGEN NV shares in Q1 2017, an estimated $4.45M.
  • PDT Partners first reported a position in QIAGEN NV in Q2 2013 and held it in 15 quarters.
  • PDT Partners's QIAGEN NV position peaked at $4.61M in Q3 2016.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on PDT Partners's 13F filing for Q1 2017, filed 15 May 2017.